These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Magnetic resonance imaging based digitally reconstructed radiographs, virtual simulation, and three-dimensional treatment planning for brain neoplasms.
    Author: Ramsey CR, Oliver AL.
    Journal: Med Phys; 1998 Oct; 25(10):1928-34. PubMed ID: 9800700.
    Abstract:
    Currently, patients with brain neoplasms must undergo both computed tomography (CT) and magnetic resonance (MR) imaging to take advantage of CT's density information and MR's soft tissue imaging capabilities. A method has been developed that allows virtual simulation, digitally reconstructed radiographs (DRRs), and 3-D treatment planning of patients with brain neoplasms to be generated using only one T1-weighted MR data set. DRRs of an anthropomorphic RANDO head phantom were generated using MR and CT imaging. The MR based DRRs provided structural information equivalent to CT based DRRs. The spatial linearity of CT and MR image sets was evaluated by measuring the percent distortion and spatial error. There was no statistical difference in spatial linearity or accuracy between the CT and MR image sets. MR and CT based treatment planning were compared using a variety of different treatment accessories, field sizes, photon energies, and gantry positions. Doses at various points throughout the head phantom were used as comparison points between CT based heterogeneous, CT based homogenous, and MR based homogenous treatment planning of the head phantom. Lithium fluoride thermoluminescent dosimeters were used to verify the dosimetric accuracy of MR based treatment planning by taking measurements at these points. For treatment plans with fields that pass through large air cavities, such as the maxillary sinus, homogenous treatment planning produces unacceptable dosimetric error (2%-4%). For treatment plans with fields that pass through the skull, MR homogenous treatment planning can be used with a dosimetric accuracy of +/- 2%.
    [Abstract] [Full Text] [Related] [New Search]